Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 371 of 5804
-
Brain pacemaker showdown: which target best eases Parkinson's symptoms?
Disease control Not yet recruitingThe primary objective of this prospective, multicenter, double-blind, randomized, crossover clinical trial is to evaluate whether Subthalamic Nucleus-Deep Brain Stimulation (STN-DBS) is more effective than Globus Pallidus Internus-Deep Brain Stimulation (GPi-DBS) in improving mot…
Phase: NA • Sponsor: Zhang Jianguo • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a simple Self-Swap replace the speculum for cervical cancer screening?
Diagnosis Recruiting nowThis clinical trial evaluates the use of self-collected vaginal samples for human papillomavirus (HPV) testing in patients referred for a colposcopy and/or cervical excisional procedures to improve cervical cancer prevention. HPV is a common virus which usually causes infections …
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
New shot could replace aspirin to stop clots after knee surgery
Disease control Recruiting nowThis study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called Acetylsalicylic Acid (ASA). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim…
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can a bispecific antibody wipe out stubborn CLL cells?
Disease control Recruiting nowThe goal of this study is to test mosunetuzumab given alone or in combination with a Bruton tyrosine kinase inhibitor (BTKi, such as ibrutinib, acalabrutinib, zanubrutinib, or pirtobrutinib) in participants with CLL (chronic lymphocytic leukemia) or small lymphocytic lymphoma (SL…
Phase: PHASE1, PHASE2 • Sponsor: Inhye Ahn • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New pill shows promise for severe eczema sufferers
Disease control OngoingThis phase 2b study is designed to evaluate the safety and efficacy of KT-621 in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD), a common form of eczema. The main goals of this study are to learn how effective KT-621 is at reducing the severity a…
Phase: PHASE2 • Sponsor: Kymera Therapeutics, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Blood test could spare thousands from unnecessary breast cancer scares
Diagnosis ENROLLING_BY_INVITATIONThe project aims to investigate whether breast cancer screening can be improved using blood tests, thereby reducing the number of unnecessary clinical mammographies. The Danish breast cancer screening program was implemented in 2007, and currently, all women aged 50-69 are invite…
Sponsor: Vejle Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
New cocktail of three drugs shows promise for tough kidney cancers
Disease control Recruiting nowThe goal of this research study is to evaluate how well and safely the study drugs sasanlimab, palbociclib, and axitinib work for treatment of participants with advanced clear cell renal cell carcinoma (ccRCC) or translocation renal cell carcinoma (tRCC). The name of the study d…
Phase: PHASE2 • Sponsor: Stephanie Berg • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New obesity drug tirzepatide aims to shed pounds and prevent diabetes
Disease control Recruiting nowThe purpose of this study is to evaluate tirzepatide within a real-world setting to assess body weight loss and incidence of type 2 diabetes in adults without diabetes who have obesity and at least one weight-related comorbid condition. Participation in the study will last about …
Phase: PHASE4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could this antibody be the key to slowing Parkinson's?
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of prasinezumab compared with placebo in participants with early-stage Parkinson's disease (PD) on stable symptomatic monotherapy with levodopa.
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New camera could save hearts: OCTAVE trial tests smarter stent placement
Disease control ENROLLING_BY_INVITATIONThe purpose is to investigate if a strategy of routine OCT based diagnosis and guidance of PCI improves clinical outcomes compared with a standard strategy of guidance by angiography in patients presenting with ACS
Phase: NA • Sponsor: Aarhus University Hospital Skejby • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New combo aims to save esophagus in advanced cancer patients
Disease control Recruiting nowThis study is a prospective, exploratory clinical study aimed at evaluating the feasibility and safety of camrelizumab combined with synchronous chemoradiotherapy as an organ-preserving strategy for locally advanced resectable esophageal squamous cell carcinoma. The study target…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Henan University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug targets Life-Threatening immune storm in rheumatic patients
Disease control Recruiting nowA study designed to evaluate the efficacy, safety, immunogenicity, PK, and PD characteristics of Plonmarlimab in patients with relapsed/refractory rheumatic and immunologic disease-associated MAS, and to explore biomarkers related to the efficacy of Plonmarlimab.
Phase: PHASE3 • Sponsor: TJ Biopharma Co., Ltd. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New drug combo aims to shrink ovarian tumors before surgery
Disease control Recruiting nowCancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess the safety and efficacy of neoadjuvant carboplatin and mirvetuximab soravtansine in participants with folate receptor alpha (FRα) -expressing adv…
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New pill could ease diabetic nerve pain without opioids
Symptom relief Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine in participants with pain associated with diabetic peripheral neuropathy (DPN).
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
New drug cocktail targets rare childhood cancer
Disease control Recruiting nowPatients participating in this study have DSRCT that has spread locally or to other parts of the body and can no longer be surgically removed without causing significant harm. Treatment will continue until the tumor progresses further, severe side effects occur, or either patien…
Phase: PHASE2 • Sponsor: Italian Sarcoma Group • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New HPV vaccine shows promise in protecting young girls and women
⭐️ VACCINE ⭐️ OngoingThis vaccine was jointly developed by Chengdu Institute of Biological Products Co., Ltd. and National Vaccine and Serum Institute, China, is co-sponsoring this clinical trial. This trial plans to enroll 1,800 female subjects aged 9-35 years, 450 in each of the 18-25 years old 3-…
Phase: PHASE3 • Sponsor: National Vaccine and Serum Institute, China • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:13 UTC
-
Can a 4-Month TB regimen work as well as 6 months?
Disease control Recruiting nowThis study is a randomized controlled trial among asymptomatic tuberculosis individuals aiming to assess whether the standard treatment duration can be shortened to 17 weeks without increasing the types or doses of anti-tuberculosis medications or 13 weeks with the high-dose rifa…
Phase: PHASE4 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Experimental ‘In vivo’ CAR-T therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis is a single-arm, open-label, single-center, dose-escalation Phase I platform study designed to evaluate the safety, tolerability, preliminary efficacy, pharmacokinetics, and pharmacodynamics of an in vivo CAR-T therapy (V001 Injection, targeting BCMA, GPRC5D, DLL3,FcRH5, etc…
Phase: EARLY_PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Precision radiation may boost transplant success in tough leukemia cases
Disease control Recruiting nowThis is an open-label, single-center, non-randomized phase I/II pilot study evaluating proton-based Total Marrow Irradiation (TMI) as part of the conditioning regimen prior to allogeneic hematopoietic stem cell transplantation (allo-HSCT) in adult patients with high-risk or relap…
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Brain training with real-time scans shows promise for depression relief
Symptom relief Recruiting nowThis study tests the efficacy of a new psychotherapeutic strategy for reducing negative attention bias (and therefore depression severity) in participants with MDD. This real-time fMRI neurofeedback therapy uses cloud-based pattern classification to decode a patient's attentional…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC